J. Khalifa

发表

Laparoscopic closure of the pouch of Douglas by a peritoneal running suture. A minimally invasive and prosthetic-free technique to prevent excessive dose delivery to the small bowel during pelvic irradiation for prostate cancer

B. Malavaud, G. Ferron, C. Chira, 2020, Clinical and translational radiation oncology.

Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer

J. Bussink, R. Apolle, W. V. Elmpt, 2020 .

Interobserver variability in the delineation of the primary lung cancer and lymph nodes on different four-dimensional computed tomography reconstructions.

M. V. van Herk, J. Theuws, J. Pomp, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Refining the risk-stratification of transrectal biopsy-detected prostate cancer by elastic fusion registration transperineal biopsies

D. Portalez, B. Malavaud, G. Ploussard, 2019, World Journal of Urology.

Novel methodology to investigate the impact of radiation dose to heart sub-structures on overall survival.

M. V. van Herk, C. Faivre-Finn, E. V. Vasquez Osorio, 2020, International journal of radiation oncology, biology, physics.

Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group

J. Blay, A. Le Cesne, S. Piperno-Neumann, 2015, BMC Cancer.

Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study.

J. Thariat, J. Salleron, J. Castelli, 2019, European journal of cancer.

Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary

J. Thariat, J. Salleron, J. Castelli, 2021, Cancers.

To exploit the 5 ‘R’ of radiobiology and unleash the 3 ‘E’ of immunoediting: ‘RE’-inventing the radiotherapy-immunotherapy combination

N. Magné, C. Rodriguez-Lafrasse, C. Chargari, 2020, Therapeutic advances in medical oncology.

Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers

W. Krajewski, S. Albisinni, A. Cimadamore, 2021, World Journal of Urology.

Gene therapy and cell therapy for the management of radiation damages to healthy tissues: Rationale and early results.

N. Magné, D. Riccobono, M. Drouet, 2019, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Brain metastases from germ cell tumor: time to reconsider radiotherapy?

C. Chevreau, J. Khalifa, A. Flechon, 2020, Critical reviews in oncology/hematology.

Subventricular zones: new key targets for glioblastoma treatment

F. Tensaouti, J. Lotterie, E. Uro-Coste, 2017, Radiation oncology.

Molecular PET imaging in adaptive radiotherapy: brain.

E. Cohen-Jonathan-Moyal, P. Payoux, A. Laprie, 2018, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies

A. Amini, L. Gaspar, C. Faivre-Finn, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Outcome of pN0 Triple‐Negative Breast Cancer with or without Lymph Node Irradiation: A Single Institution Experience

F. Dalenc, T. Filleron, E. Jouve, 2016, The breast journal.

Emerging treatment paradigms for brain metastasis in non-small-cell lung cancer: an overview of the current landscape and challenges ahead.

C. Faivre-Finn, J. Khalifa, D. Ulahannan, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy in the Era of Immunotherapy With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas?

J. Mazières, M. Ayyoub, C. Gomez-Roca, 2021, Frontiers in Oncology.

Radiotherapy for primary lung cancer.

F. Mornex, D. Lerouge, J. Darréon, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

RADIORYTHMIC: Phase III, Opened, Randomized Study of Postoperative Radiotherapy Versus Surveillance in Stage IIb/III of Masaoka Koga Thymoma after Complete Surgical Resection.

N. Girard, T. Molina, L. Thiberville, 2021, Clinical lung cancer.

Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey

J. Bibault, J. Faivre, C. Hennequin, 2022, Clinical and translational radiation oncology.

Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review

J. Clavier, M. Loo, J. Khalifa, 2021, Cancers.

Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I Study.

J. Mazières, C. Toulas, I. Rouquette, 2017, Clinical lung cancer.

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis

D. Pouessel, U. Schick, E. Cohen-Jonathan Moyal, 2020, Cancers.

Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study

P. Giraud, N. Salem, D. Peiffert, 2022, Frontiers in Oncology.

Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging

N. Magné, F. Tensaouti, E. Uro-Coste, 2019, BMC Cancer.

Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?

Corinne Johnson, Jonathan Khalifa, Fatima Tensaouti, 2016, Journal of Neuro-Oncology.

Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma

F. Tensaouti, I. Berry, J. Lotterie, 2017, Neuroradiology.

[Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy].

J. Thariat, R. Bensadoun, P. Fenoglietto, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer

J. Bussink, R. Apolle, W. V. van Elmpt, 2019, Acta oncologica.

A method to combine target volume data from 3D and 4D planned thoracic radiotherapy patient cohorts for machine learning applications.

Marcel van Herk, Andre Dekker, Corinne Johnson, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Focus on stereotactic radiotherapy: A new way to treat severe ventricular arrhythmias?

L. Fauchier, É. Marijon, F. Sacher, 2021, Archives of cardiovascular diseases.

Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I–II trial of radiotherapy/tipifarnib combination

P. Celsis, P. Péran, I. Berry, 2015, Journal of Neuro-Oncology.

Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: a retrospective bicenter study by the SFRO Brachytherapy Group.

R. Schiappa, D. Peiffert, J. Hannoun-levi, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation

N. Magné, P. Péran, F. Tensaouti, 2016, European Radiology.

IDEAL 2a Phase II Study of Ultrafocal Brachytherapy for Low- and Intermediate-risk Prostate Cancer.

T. Brun, J. Bachaud, D. Portalez, 2018, International journal of radiation oncology, biology, physics.

Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder.

N. Magné, S. Culine, R. de Crevoisier, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa).

S. Supiot, S. Krhili, J. Khalifa, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Effect of orbital radiotherapy on the outcome of surgical orbital decompression for thyroid-associated orbitopathy (TAO): a retrospective study in 136 patients

P. Caron, F. Boutault, J. Khalifa, 2019, Endocrine.

Impact of radiation on host immune system in patients treated with chemoradiotherapy and durvalumab consolidation for unresectable locally advanced non-small cell lung cancer

J. Mazières, A. Lusque, J. Khalifa, 2023, Frontiers in oncology.

Impact of radiotherapy on survival in resected or unresectable anaplastic thyroid carcinomas, a Rare Cancer Network study.

Y. Drouet, J. Thariat, X. Sun, 2022, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

The role of radiation therapy for de novo metastatic bladder and renal cancers.

R. de Crevoisier, D. Pasquier, P. Blanchard, 2023, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Radiotherapy in the management of synchronous metastatic lung cancer.

S. Thureau, F. Riet, D. Antoni, 2023, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment

A. Laprie, T. Filleron, L. Vieillevigne, 2014, Radiation oncology.

[Impact of immunotherapy on the therapeutic strategy for the management of stage I non-small cell lung cancer: The radiation oncologist's point of view].

J. Khalifa, 2023, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

10-Year Locoregional Control with Postoperative External Beam Radiotherapy in Patients with Locally Advanced High-Risk Non-Anaplastic Thyroid Carcinoma De Novo or at Relapse, a Propensity Score Analysis

Jianji Pan, T. Sio, J. Thariat, 2019, Cancers.

N. Magné, F. Tensaouti, E. Uro-Coste, 2019, BMC Cancer.

Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment

A. Laprie, T. Filleron, L. Vieillevigne, 2014, Radiation Oncology.